Nasal Spray "Vaccine" Launched in India — Will be Exported upon Approval
Another "vaccine" that must be rejected. And several reasons why. Indian company Bharat Biotech — global top exporter of "vaccines" for COVID, launches 1st nasal spray "vaccine"
On today’s edition of: “Nope, probably don’t want that one either..”
This newly released nasal spray (non mRNA) “vaccine” will likely proliferate everywhere due to its inexpensive nature. It will likely be widely exported (as long as it is approved .. more on that later) & while it may possibly be more safe as compared to Sinopharm’s forthcoming mRNA Gene Serum injections…which are also likely to be export-friendly — in a more lethal form — it’s probably better to Just Say No & skip this nasal spray too, until long term safety studies can be funded & completed.
Here’s the glaring red flag:
Hyderabad-based companies also intend to export iNCOVACC overseas once it gets licensed.
via India Times
Will the FDA approve this in the United States?
Below are some excerpts from this Hindustan Times piece:
What: “iNCOVACC (BBV154) was approved by the Drugs Controller General of India (DCGI) in November for limited emergency use as a heterologous booster dose in adults. It is a pre-fusion stabilised recombinant replication-deficient adenovirus vectored vaccine.”
Why: “Immune responses at the site of infection (in the nasal mucosa) are critical for preventing Covid-19 infection and transmission.”
How much: “Bharat Biotech said the vaccine is now available on CoWIN, and is priced at ₹800 for private markets and ₹325 for supplies to the central and state governments.”
In USD:
800 Rupees = $8.91
325 Rupees = $3.99
Another why: “[…] eliminates the need for syringes, needles, alcohol wipes, bandages, and other items, saving money on procurement, distribution, storage, and biomedical waste disposal […] can be kept in a regular refrigerator at temperatures ranging from 2-8°C, making it simple to store and distribute across the country.”
How: “[…] coats the mucous membrane in the nasal pathway with an antibody layer, preventing infection at the source.”
The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world.
"As the world's first intranasal Covid-19 vaccine, this is a glorious tribute to the call for Atma Nirbhar Bharat (self-sufficiency in India)," Mandaviya said at the launch. Bharat Biotech said it is intended for low-and middle-income countries.
via Hindustan Times
Need another good reason to say no?
Bharat previously failed Good Manufacturing Practices according to the WHO for Covaxin — another “vaccine” they produced.
When the WHO fails your company for not having “Good Manufacturing Practices…It’s time to call it quits, because your company has “Not Good Manufacturing Practices.”
Pass. I don’t think i’ll ever accept a “vaccine” ever again but will rely on my immune system. Pharmaceuticals are dead to me
Maybe WHO failed them because it wouldn't kill enough people and its too cheap. I’d take a nasal spray over an injection any day (not that I would take either). And no live virus like the nasal flu vax